Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Looking for ways to earn extra cash when busy? Explore practical methods to increase your income without sacrificing your time.
19,658 articlesJohnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Retirees face roughly $36,000 per year in aging-in-place costs, rising faster than Social Security. A carefully craft...
Two retirees begin with $1 million each and choose opposite paths: one seeks high current income, the other compounds...
When a PayPal vice president sold a large block of stock, investors naturally wonder what it signals. This guide brea...
A veteran journalist outlines Elliott Investment Management’s influence on Norwegian Cruise Line amid a strong cruise...
As the S&P 500 sits near record highs, leadership is shifting toward defensive names. This article explains why consu...
When a smart-home name rallies, traders pay attention. This piece breaks down why resideo technologies stock popped o...
On March 2, energy and defense names spearheaded gains as oil jumped, while travel and leisure stocks softened. This ...
A fashion brand founder downsizes a high-revenue operation to pursue profitability, exemplifying a growing trend amon...
Freightcar America (Rail) earnings can signal the health of a cyclical market. This guide breaks down the numbers, si...
A fresh stake of roughly $4.5 million by a value-focused firm in Workiva raises questions about what comes next for W...
Two discount retailers face off for 2026 returns, with Dollar Tree highlighting a store-format push and Dollar Genera...